FORM 8-K

Company

BIOCRYST PHARMACEUTICALS INC

Filed

December 21, 2020

Period of Report

December 21, 2020

Accession Number

0001171843-20-008658

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →